Amarin Corp Plc (AMRN)

[picasel]

HDG; It is my belief that the NCE case is all but in the books as far as Amarin,the FDA and the courts are concerned. At this point any further litigation concerning Watson is side noise which will be addressed as another issue even though related, but should not preclude OB admission of Vascepa's NCE. I do not think FDA's legal team would allow or advise the FDA to withhold this OB entry and risk the ire of the Court of His Honorable Randy Moss. He did not think highly of their earlier antics with respect to Amarin's treatment at their hands and this OB omission would further test his judicial temperament should it come to his attention.